The effects of Panax notoginseng saponins on the cytokines and peritoneal function in rats with peritoneal fibrosis

References

• Marshall MR, Walker RC, Polkinghorne KR, Lynn KL. Survival on home dialysis in New Zealand. PLoS One. 2014;9(5):e96847
   PubMed Web of Science ®Google Scholar
• Lee H, Manns B, Taub K, et al. Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002;40(3):611–622
   PubMed Web of Science ®Google Scholar
• Jain AK, Blake P, Cordy P, et al. Global trends in rates of peritoneal dialysis. J Am Soc Nephrol. 2012;23(3):533–544
   PubMed Web of Science ®Google Scholar
• Krediet RT. Peritoneal physiology-impact on solute and fluid clearance. Adv Ren Replace Ther. 2000;7(4):271–279
   PubMedGoogle Scholar
• Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med. 2000;342(18):1350–1358
   PubMed Web of Science ®Google Scholar
• Yao HW, Xie QM, Chen JQ, et al. TGF-beta1 induces alveolar epithelial to mesenchymal transition in vitro. Life Sci. 2004;76(1):29–37
   PubMed Web of Science ®Google Scholar
• Willis BC, duBois RM, Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc. 2006;3(4):377–382
   PubMedGoogle Scholar
• Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 2009;19(2):156–172
   PubMed Web of Science ®Google Scholar
• Lai KN, Lai KB, Lam CW, et al. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 2000;35(4):644–652
   PubMed Web of Science ®Google Scholar
• Margetts PJ, Kolb M, Galt T, et al. Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol. 2001;12(10):2029–2039
   PubMed Web of Science ®Google Scholar
• Loureiro J, Aguilera A, Selgas R, et al. Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol. 2011;22(9):1682–1695
   PubMed Web of Science ®Google Scholar
• Leung JC, Chan LY, Tam KY, et al. Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis. Nephrol Dial Transplant. 2009;24(2):458–469
   PubMed Web of Science ®Google Scholar
• Mizutani M, Ito Y, Mizuno M, et al. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Am J Physiol Renal Physiol. 2010;298(3):F721–F733
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang L, He W, et al. Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in rats submitted to peritoneal dialysis. Int J Mol Sci. 2014;15(7):12959–12971
   PubMed Web of Science ®Google Scholar
• Ko KI, Park KS, Lee MJ, et al. Increased dialysate MCP-1 is associated with cardiovascular mortality in peritoneal dialysis patients: A prospective observational study. Am J Nephrol. 2014;40(4):291–299
   PubMed Web of Science ®Google Scholar
• Ng TB. Pharmacological activity of sanchi ginseng (Panax notoginseng). J Pharm Pharmacol. 2006;58(8):1007–1019
   PubMed Web of Science ®Google Scholar
• Zhang JH, Wang JP, Wang HJ. Clinical study on effect of total panax notoginseng saponins on immune related inner environment imbalance in rheumatoid arthritis patients. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007;27(7):589–592
   PubMedGoogle Scholar
• Liu X, Huang Z, Zou X, et al. Panax notoginseng saponins attenuates cisplatin-induced nephrotoxicity via inhibiting the mitochondrial pathway of apoptosis. Int J Clin Exp Pathol. 2014;7(12):8391–8400
   PubMed Web of Science ®Google Scholar
• Wu H, Feng YZ, Gu ZL, et al. Effects of PNS on the change of pulmonary pathology and expression of TGF-β1 in rats pulmonary fibrosis. SuZhou Da Xue Xue Bao. 2009;29(1):29–32
   Google Scholar
• Krediet RT. The peritoneal membrane in chronic peritoneal dialysis. Kidney Int. 1999;55(1):341–356
   PubMed Web of Science ®Google Scholar
• Williams JD, Craig KJ, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13(2):470–479
   PubMed Web of Science ®Google Scholar
• Breborowicz A, Oreopoulos DG. Evidence for the presence of chronic inflammation during peritoneal dialysis: Therapeutic implications. Perit Dial Int. 1997;17 (Suppl 2):S37–S41
   PubMed Web of Science ®Google Scholar
• Kang DH, Hong YS, Lim HJ, Choi JH, Han DS, Yoon KI. High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-beta1 of human peritoneal mesothelial cells: Effect of cytokine costimulation. Perit Dial Int. 1999;19(3):221–230
   PubMed Web of Science ®Google Scholar
• Zhang W, Chen G, Deng CQ. Effects and mechanisms of total panax notoginseng saponins on proliferation of vascular smooth muscle cells with plasma pharmacology method. J Pharm Pharmacol. 2012;64(1):139–145
   PubMed Web of Science ®Google Scholar
• Dai JP, Chen XX, Zhu DX, et al. Panax notoginseng saponins inhibit areca nut extract-induced oral submucous fibrosis in vitro. J Oral Pathol Med. 2014;43(6):464–470
   PubMed Web of Science ®Google Scholar
• Xie XS, Yang M, Liu HC, et al. Ginsenoside Rg1, a major active component isolated from Panax notoginseng, restrains tubular epithelial to myofibroblast transition in vitro. J Ethnopharmacol. 2009;122(1):35–41
   PubMed Web of Science ®Google Scholar
• Peng XD, Dai LL, Huang CQ, et al. Relationship between anti-fibrotic effect of Panax notoginseng saponins and serum cytokines in rat hepatic fibrosis. Biochem Biophys Res Commun. 2009;388(1):31–34
   PubMed Web of Science ®Google Scholar
• Wada T, Furuichi K, Sakai N, et al. Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J Am Soc Nephrol. 2004;15(4):940–948
   PubMed Web of Science ®Google Scholar
• Xu J, Lin SC, Chen J, et al. CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis. Am J Physiol Heart Circ Physiol. 2011;301(2):H538–H547
   PubMed Web of Science ®Google Scholar
• Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Rollin BJ, Tesch GH. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int. 2006;69(1):73–80
   PubMed Web of Science ®Google Scholar